Asia
Dr. Amin Al Amiri: the Programs are part of ministry’s initiatives during ‘Year of Zayed’ to provide quality of care to patients
The world’s leading experts in Parkinson’s disease and Movement Disorders will present the latest research findings and state-of-the-art treatment options at the International Parkinson and Movement Disorder Society’s (MDS) International Congress of Parkinson’s Disease and Movement Disorders® in Hong Kong, October 5-9, 2018.
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai’s antiepileptic drug (AED) Fycompa (perampanel)
Kangstem Biotech today announces the selection of MaSTherCell as its contract manufacturing partner for its European clinical trial of FURESTEM-AD(R).
The Spine Care Center of Prime Hospital, the UAE’s leading healthcare service provider, has successfully performed a delicate spinal operation using minimally invasive surgical technologies on an Argentinian lady suffering from low back pain.
Ministry presents initiatives at 12th International Law Enforcement Intellectual Property Crime Conference
One-year scheme under ATAA & TADAMON initiatives for financially challenged patients
Initiative highlights commitment to the highest health and safety standards in the workplace in cooperation with the American Hospital in Dubai
Facility is acquired from Porton Pharma Solutions Ltd., and operated with GMP compliance.
Gamida Cell Ltd. filed for a $69 million initial public offering for the Nasdaq exchange, according to a filing submitted last week to the U.S. Securities and Exchange Commission, Israel’s Calcalist first reported last week.
PRESS RELEASES